scispace - formally typeset
P

Pilar Bueno Siqueira Mercer

Publications -  6
Citations -  80

Pilar Bueno Siqueira Mercer is an academic researcher. The author has contributed to research in topics: Olfaction & Framingham Risk Score. The author has an hindex of 3, co-authored 6 publications receiving 49 citations.

Papers
More filters
Journal ArticleDOI

Olfactory dysfunction in Alzheimer's disease Systematic review and meta-analysis.

TL;DR: Among the olfactory domains, except memory, identification appears to be the most altered in AD, and the possibility of including tests that specifically evaluate the identification of odors as an item in early diagnostic evaluation should be explored.
Journal ArticleDOI

Olfactory impairment in frontotemporal dementia: A systematic review and meta-analysis.

TL;DR: Patients with the frontotemporal dementia behavioral variant seem to present with alterations in odor identification, but with preserved discrimination, therefore, it is concluded that olfactory evaluation in these patients is possibly impacted by cognitive alterations and not by sensory deficits.
Journal ArticleDOI

Restless legs syndrome in Parkinson's disease and increased cardiovascular risk.

TL;DR: Patients with Parkinson's disease and RLS have a higher prevalence of dyslipidemia than patients without RLS, suggesting a correlation between restless legs and hyperlipids, and the hypothesis of the real interference of the syndrome treatment as a protective factor for cardiovascular risk was generated.
Journal ArticleDOI

Profile and generalist physician knowledge about neurology in emergency department: headache management

TL;DR: General practice physicians often do not feel confident when performing neurological exams, demonstrating low knowledge about the topic.
Journal ArticleDOI

Testes de rastreio para alterações psiquiátricas em esclerose múltipla - Revisão sistemática com metanálise

TL;DR: Uma revisão sistemática com metanálise visando evidenciar as ferramentas de rastreio psiquiátrico mais adequadas na abordagem de pacientes adultos com esclerose múltipla avaliadas por estudos de acurácia diagnóstica.